Legal and Medical Aspects of Off-Label Medication Use. Point of View
The current state of the Russian and foreign regulatory framework for off-label prescription of medicines is presented in the article. The existing problems of this specific drug therapy and possible solutions are described. Unfortunately, there are some gaps in the Russian legislation regarding the...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1869 |
| _version_ | 1797232130589196288 |
|---|---|
| author | O. V. Tsygankova T. I. Batluk L. D. Latyntseva D. Y. Platonov N. M. Akhmedzhanov |
| author_facet | O. V. Tsygankova T. I. Batluk L. D. Latyntseva D. Y. Platonov N. M. Akhmedzhanov |
| author_sort | O. V. Tsygankova |
| collection | DOAJ |
| description | The current state of the Russian and foreign regulatory framework for off-label prescription of medicines is presented in the article. The existing problems of this specific drug therapy and possible solutions are described. Unfortunately, there are some gaps in the Russian legislation regarding the off-label medication use. Based on the clinical reality, in some cases, the “off-label” drugs prescription can be justified by the clinical condition of the patient, the lack of alternative approved drugs, and the availability of published scientific data that create the prerequisites for the effectiveness of this approach. When off-label drug prescribing as a forced measure, the doctor must provide a rationale for this prescription in the medical documentation, the conclusion of the consultation (with the participation of relevant specialists and the clinical pharmacologist) or the medical commission (with the participation of the administration representative), and the written informed consent of the patient or his legal representative. This information should be actively communicated to doctors in order to increase their legal literacy and prevent possible negative and legal consequences. |
| first_indexed | 2024-03-08T14:01:41Z |
| format | Article |
| id | doaj.art-00c33b5ae1d248e3ae6a3628716e351c |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:55:23Z |
| publishDate | 2019-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-00c33b5ae1d248e3ae6a3628716e351c2024-04-01T07:43:37ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-03-0115113013410.20996/1819-6446-2019-15-1-130-1341584Legal and Medical Aspects of Off-Label Medication Use. Point of ViewO. V. Tsygankova0T. I. Batluk1L. D. Latyntseva2D. Y. Platonov3N. M. Akhmedzhanov4Research Institute of Internal and Preventive Medicine – Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State Medical UniversityResearch Institute of Internal and Preventive Medicine – Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of SciencesResearch Institute of Internal and Preventive Medicine – Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of SciencesTver State Medical UniversityNational Research Center for Preventive MedicineThe current state of the Russian and foreign regulatory framework for off-label prescription of medicines is presented in the article. The existing problems of this specific drug therapy and possible solutions are described. Unfortunately, there are some gaps in the Russian legislation regarding the off-label medication use. Based on the clinical reality, in some cases, the “off-label” drugs prescription can be justified by the clinical condition of the patient, the lack of alternative approved drugs, and the availability of published scientific data that create the prerequisites for the effectiveness of this approach. When off-label drug prescribing as a forced measure, the doctor must provide a rationale for this prescription in the medical documentation, the conclusion of the consultation (with the participation of relevant specialists and the clinical pharmacologist) or the medical commission (with the participation of the administration representative), and the written informed consent of the patient or his legal representative. This information should be actively communicated to doctors in order to increase their legal literacy and prevent possible negative and legal consequences.https://www.rpcardio.online/jour/article/view/1869off-label uselegal aspectsmedical aspects |
| spellingShingle | O. V. Tsygankova T. I. Batluk L. D. Latyntseva D. Y. Platonov N. M. Akhmedzhanov Legal and Medical Aspects of Off-Label Medication Use. Point of View Рациональная фармакотерапия в кардиологии off-label use legal aspects medical aspects |
| title | Legal and Medical Aspects of Off-Label Medication Use. Point of View |
| title_full | Legal and Medical Aspects of Off-Label Medication Use. Point of View |
| title_fullStr | Legal and Medical Aspects of Off-Label Medication Use. Point of View |
| title_full_unstemmed | Legal and Medical Aspects of Off-Label Medication Use. Point of View |
| title_short | Legal and Medical Aspects of Off-Label Medication Use. Point of View |
| title_sort | legal and medical aspects of off label medication use point of view |
| topic | off-label use legal aspects medical aspects |
| url | https://www.rpcardio.online/jour/article/view/1869 |
| work_keys_str_mv | AT ovtsygankova legalandmedicalaspectsofofflabelmedicationusepointofview AT tibatluk legalandmedicalaspectsofofflabelmedicationusepointofview AT ldlatyntseva legalandmedicalaspectsofofflabelmedicationusepointofview AT dyplatonov legalandmedicalaspectsofofflabelmedicationusepointofview AT nmakhmedzhanov legalandmedicalaspectsofofflabelmedicationusepointofview |